By Reuters Staff
(Reuters) – U.S. drugmaker Acceleron Pharma Inc is in advanced talks to be acquired by a large pharmaceutical company for more than $11 billion, Bloomberg News reported on Friday, citing people familiar with the matter.
The acquisition…

Click here to view the original article.